8 results · 20ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

3Dicom MD

FDA 510(k)
FDA Class 2 ·Radiology

Caplugs/Evergreen

FDA UDI
CAPlugs·00810044201079·15 mL Sterile Centrifuge Tubes with Screw Caps

PENTAX EPK-I5010 VIDEO PROCESSOR

FDA 510(k)
FDA Class 2 ·Gastroenterology, Urology

PORTA SOLDER 1080 W

FDA 510(k)
FDA Class 2 ·Dental

HEARTMATE II LVAS

FDA Adverse Event
Death ·THORATEC CORP.·Product code DSQ·October 31, 2014

PERCLOSE PROGLIDE 6F SUTURE MEDIATED CLOSURE (SMC) SYSTEM

FDA Adverse Event
Injury ·AV-TEMECULA-CT·Product code MGB·August 25, 2011

PK DISSECTING FORCEPS INSTRUMENT

FDA Adverse Event
Malfunction ·INTUITIVE SURGICAL,INC.·Product code NAY·July 12, 2013

Brand Name: SenTiva" Product Name: VNS Therapy" SenTiva", Model 1000 Model/Catalog Number: 1000 Software Version: NA Product Description: The LivaNova VNS Therapy" System, used for Vagus Nerve Stimulation (VNS), consists of an implantable VNS Therapy generator, lead, and external programming system used to change stimulation settings. The generator is an implantable, multi-programmable pulse generator that delivers electrical signals to the vagus nerve through the lead. The generator is housed in a hermetically sealed titanium case and is powered by a single battery. Electrical signals are transmitted from the generator to the vagus nerve by the lead. The lead and the generator make up the implantable portion of the VNS Therapy System. The VNS Therapy Programming System includes a computer pre-installed with VNS Therapy programming software and a programming wand. The physician uses the programming system to read and change generator settings. The Model 1000 Generator was commercially approved for distribution in the U.S. on October 3, 2017 via PMA P970003/S210. Component: The LivaNova VNS Therapy" System, used for Vagus Nerve Stimulation (VNS).

FDA Enforcement
Class II ·Ongoing·LivaNova USA, Inc.·February 5, 2025